Pathway to Cures (P2C), the venture philanthropy fund of the National Bleeding Disorders Foundation (NBDF), encourages biotech and pharmaceutical companies that are developing treatments and cures for ...

To mark the 10th anniversary of Bleeding Disorders Awareness Month, the National Bleeding Disorders Foundation (NBDF) and Talk About It are teaming up for Bleeding.org LIVE! -- the first-ever ...

The Departments of Pathology and Pediatrics of Father Muller Medical College successfully conducted HAEM INSIGHT 3.0, a ...

Bleeding disorders can turn the most mild of episodes a serious situation and to shed light on the conditions that affect ...

At some point in our EMT and paramedic training, we learned how dangerous hemophilia and other bleeding disorders can be for trauma patients. We also learned there was not much we could do for them in ...

Caplin Steriles (Caplin), a Subsidiary Company of Caplin Point Laboratories, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug ...

NEW YORK, Feb. 26, 2026 /PRNewswire/ -- The National Bleeding Disorders Foundation (NBDF) announces the launch of Educate to Elevate, a multi-year initiative designed to raise public awareness, ...

For decades, people with hemophilia have benefited from remarkable advances in treatment. Meanwhile, many people living with von Willebrand disease (VWD) have continued relying on therapies developed ...

Von Willebrand disease (VWD) is the most common inherited bleeding disorder and predisposes patients to hemorrhagic complications following trauma or invasive procedures. Chiropractic spinal ...

Abstract: Objective: Von Willebrand Disease (VWD), the most common inherited bleeding disorder affecting 0.1% to 1% of the population, causes extensive mucocutaneous bleeding across various clinical ...